Petersen Kitt Falk, Dufour Sylvie, Befroy Douglas, Lehrke Michael, Hendler Rosa E, Shulman Gerald I
Yale University School of Medicine, Department of Internal Medicine, 300 Cedar St., S263 TAC, P.O. Box 9812, New Haven, CT 06520-8020, USA.
Diabetes. 2005 Mar;54(3):603-8. doi: 10.2337/diabetes.54.3.603.
To examine the mechanism by which moderate weight reduction improves basal and insulin-stimulated rates of glucose metabolism in patients with type 2 diabetes, we used (1)H magnetic resonance spectroscopy to assess intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) content in conjunction with hyperinsulinemic-euglycemic clamps using [6,6-(2)H(2)]glucose to assess rates of glucose production and insulin-stimulated peripheral glucose uptake. Eight obese patients with type 2 diabetes were studied before and after weight stabilization on a moderately hypocaloric very-low-fat diet (3%). The diabetic patients were markedly insulin resistant in both liver and muscle compared with the lean control subjects. These changes were associated with marked increases in IHL (12.2 +/- 3.4 vs. 0.6 +/- 0.1%; P = 0.02) and IMCL (2.0 +/- 0.3 vs. 1.2 +/- 0.1%; P = 0.02) compared with the control subjects. A weight loss of only approximately 8 kg resulted in normalization of fasting plasma glucose concentrations (8.8 +/- 0.5 vs. 6.4 +/- 0.3 mmol/l; P < 0.0005), rates of basal glucose production (193 +/- 7 vs. 153 +/- 10 mg/min; P < 0.0005), and the percentage suppression of hepatic glucose production during the clamp (29 +/- 22 vs. 99 +/- 3%; P = 0.003). These improvements in basal and insulin-stimulated hepatic glucose metabolism were associated with an 81 +/- 4% reduction in IHL (P = 0.0009) but no significant change in insulin-stimulated peripheral glucose uptake or IMCL (2.0 +/- 0.3 vs. 1.9 +/- 0.3%; P = 0.21). In conclusion, these data support the hypothesis that moderate weight loss normalizes fasting hyperglycemia in patients with poorly controlled type 2 diabetes by mobilizing a relatively small pool of IHL, which reverses hepatic insulin resistance and normalizes rates of basal glucose production, independent of any changes in insulin-stimulated peripheral glucose metabolism.
为研究适度减重改善2型糖尿病患者基础及胰岛素刺激的葡萄糖代谢率的机制,我们使用氢磁共振波谱法评估肝内脂质(IHL)和肌细胞内脂质(IMCL)含量,并结合使用[6,6-(2)H(2)]葡萄糖的高胰岛素-正常血糖钳夹技术来评估葡萄糖生成率和胰岛素刺激的外周葡萄糖摄取率。对8例肥胖2型糖尿病患者在采用适度低热量极低脂肪饮食(3%)体重稳定前后进行了研究。与瘦的对照受试者相比,糖尿病患者在肝脏和肌肉中均存在明显的胰岛素抵抗。与对照受试者相比,这些变化与IHL(12.2±3.4%对0.6±0.1%;P = 0.02)和IMCL(2.0±0.3%对1.2±0.1%;P = 0.02)的显著增加相关。仅约8 kg的体重减轻导致空腹血糖浓度正常化(8.8±0.5对6.4±0.3 mmol/l;P < 0.0005)、基础葡萄糖生成率正常化(193±7对153±10 mg/min;P < 0.0005)以及钳夹期间肝葡萄糖生成的抑制百分比正常化(29±22对99±3%;P = 0.003)。基础及胰岛素刺激的肝脏葡萄糖代谢的这些改善与IHL降低81±4%相关(P = 0.0009),但胰岛素刺激的外周葡萄糖摄取或IMCL无显著变化(2.0±0.3%对1.9±0.3%;P = 0.21)。总之,这些数据支持以下假说:适度减重通过动员相对少量的IHL使控制不佳的2型糖尿病患者空腹高血糖正常化,这可逆转肝脏胰岛素抵抗并使基础葡萄糖生成率正常化,而与胰岛素刺激的外周葡萄糖代谢的任何变化无关。